{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:23:57Z","timestamp":1788870237301,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"crossref","award":["147787"],"award-info":[{"award-number":["147787"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"crossref","award":["167153"],"award-info":[{"award-number":["167153"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"crossref","award":["164778\/V50"],"award-info":[{"award-number":["164778\/V50"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"crossref"}]},{"name":"South-East Norway Health Authority","award":["123\/2004"],"award-info":[{"award-number":["123\/2004"]}]},{"name":"Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.schres.2012.10.021","type":"journal-article","created":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T00:45:29Z","timestamp":1353545129000},"page":"84-89","source":"Crossref","is-referenced-by-count":19,"title":["Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder"],"prefix":"10.1016","volume":"143","author":[{"given":"P. Andreas","family":"Ringen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Melle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiah O.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Agartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Spigset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjetil","family":"Sundet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole A.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2012.10.021_bb0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/JCP.0b013e3181a45e78","article-title":"Evaluation of a urine on-site drugs of abuse screening test in patients admitted to a psychiatric emergency unit","volume":"29","author":"Bagoien","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2012.10.021_bb0010","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jpsychires.2007.09.002","article-title":"Suicide attempts of schizophrenia patients: A case-controlled study in tertiary care","volume":"42","author":"Barak","year":"2008","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2012.10.021_bb0015","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2012.10.021_bb0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.schres.2007.05.026","article-title":"Accuracy of self-reported premorbid functioning in schizophrenia","volume":"97","author":"Brill","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.10.021_bb0025","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/schbul\/8.3.470","article-title":"Measurement of premorbid adjustment in chronic schizophrenia","volume":"8","author":"Cannon-Spoor","year":"1982","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2012.10.021_bb0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0006-3223(01)01134-9","article-title":"A neurobiological basis for substance abuse comorbidity in schizophrenia","volume":"50","author":"Chambers","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"Suppl. 3","key":"10.1016\/j.schres.2012.10.021_bb0045","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1046\/j.1360-0443.95.11s3.5.x","article-title":"Truth or consequences: the validity of self-report data in health services research on addictions","volume":"95","author":"Del Boca","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.schres.2012.10.021_bb0195","series-title":"Norwegian manual supplement","article-title":"California Verbal Learning Test, second edition (CVLT-II)","author":"Delis","year":"2004"},{"key":"10.1016\/j.schres.2012.10.021_bb0200","series-title":"Norwegian manual supplement","article-title":"The Delis-Kaplan Executive Function System (D-KEFS)","author":"Delis","year":"2005"},{"key":"10.1016\/j.schres.2012.10.021_bb0060","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1176\/ajp.148.2.224","article-title":"Drug abuse in schizophrenic patients: clinical correlates and reasons for use","volume":"148","author":"Dixon","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2012.10.021_bb0040","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis","volume":"29","author":"D'Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2012.10.021_bb0205","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.biopsych.2004.12.006","article-title":"Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction","volume":"57","author":"D'Souza","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2012.10.021_bb0070","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1176\/ajp.2007.164.3.402","article-title":"Schizophrenia and co-occurring substance use disorder","volume":"164","author":"Green","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2012.10.021_bb2070","first-page":"1","article-title":"The validity of d prime as a working memory index: results from the \"Bergen n-back task\"","author":"Haatveit","year":"2010","journal-title":"J. Clin. Exp. Neuropsychol"},{"key":"10.1016\/j.schres.2012.10.021_bb0075","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2011.02.021","article-title":"Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia","volume":"128","author":"Ho","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.10.021_bb0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2012.10.021_bb0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-0447.2005.00554.x","article-title":"The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis","volume":"112","author":"Lambert","year":"2005","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2012.10.021_bb0095","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1192\/bjp.185.2.108","article-title":"Premorbid adjustment in first-episode non-affective psychosis: distinct patterns of pre-onset course","volume":"185","author":"Larsen","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2012.10.021_bb0100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archpsyc.1994.03950040017002","article-title":"Cannabis abuse and the course of recent-onset schizophrenic disorders","volume":"51","author":"Linszen","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2012.10.021_bb0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/neuro.09.053.2009","article-title":"Cannabis use and cognition in schizophrenia","volume":"3","author":"Loberg","year":"2009","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.schres.2012.10.021_bb0110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.drugalcdep.2009.05.027","article-title":"Extended urinary [Delta]9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure","volume":"105","author":"Lowe","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.schres.2012.10.021_bb0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0920-9964(02)00523-6","article-title":"Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences","volume":"67","author":"Margolese","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.10.021_bb0120","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1465-3362.2009.00132.x","article-title":"An overview of systematic reviews on cannabis and psychosis: discussing apparently conflicting results","volume":"29","author":"Minozzi","year":"2010","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.schres.2012.10.021_bb0125","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","article-title":"Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review","volume":"370","author":"Moore","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2012.10.021_bb0130","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1017\/S0033291709005522","article-title":"The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning","volume":"39","author":"Morrison","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2012.10.021_bb0135","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nrn2253","article-title":"Cannabis, the mind and society: the hash realities","volume":"8","author":"Murray","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.schres.2012.10.021_bb0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.comppsych.2006.03.008","article-title":"Generalizability studies of the Global Assessment of Functioning-Split version","volume":"48","author":"Pedersen","year":"2007","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2012.10.021_bb0145","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.schres.2011.02.017","article-title":"The effects of cannabis use on neurocognition in schizophrenia: A meta-analysis","volume":"128","author":"Rabin","year":"2011","journal-title":"Schizophr. Res."},{"issue":"9","key":"10.1016\/j.schres.2012.10.021_bb0210","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1017\/S003329170700236X","article-title":"Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder","volume":"38","author":"Ringen","year":"2008","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2012.10.021_bb0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0920-9964(00)00063-3","article-title":"Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia","volume":"48","author":"Salyers","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.10.021_bb0215","series-title":"Reports on specific drugs","author":"SAMHSA","year":"2011"},{"key":"10.1016\/j.schres.2012.10.021_bb0165","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","article-title":"Intraclass correlations: uses in assessing rater reliability","volume":"86","author":"Shrout","year":"1979","journal-title":"Psychol. Bull."},{"issue":"1","key":"10.1016\/j.schres.2012.10.021_bb0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/schbul\/sbp034","article-title":"Neurocognitive Dysfunction in Bipolar and Schizophrenia Spectrum Disorders Depends on History of Psychosis Rather Than Diagnostic Group","volume":"37","author":"Simonsen","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2012.10.021_bb0175","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-1781(98)00038-9","article-title":"Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I\/P)","volume":"79","author":"Ventura","year":"1998","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2012.10.021_bb0220","series-title":"Norwegian manual supplement","article-title":"Wechsler Adult Intelligence Scale, third edition (WAIS-III)","author":"Wechsler","year":"2003"},{"key":"10.1016\/j.schres.2012.10.021_bb0185","series-title":"Norwegian manual supplement","article-title":"Wechsler Abbreviated Scale of Intelligence (WASI)","author":"Wechsler","year":"2007"},{"key":"10.1016\/j.schres.2012.10.021_bb0190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1176\/ajp.155.1.127","article-title":"Validity of substance use self-reports in dually diagnosed outpatients","volume":"155","author":"Weiss","year":"1998","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2012.10.021_bb0225","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/schbul\/sbq079","article-title":"The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample","volume":"38","author":"Yucel","year":"2012","journal-title":"Schizophr. Bull."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996412005932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996412005932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T18:27:14Z","timestamp":1687804034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996412005932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0920996412005932"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2012.10.021","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}